Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human Breast Cancer cells: Control vs Treated with Palbociclib

ABSTRACT: Human Breast Cancer cells: Control vs Treated with Palbociclib

PROVIDER: PRJNA563027 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression profiles between the palbociclib monotherpy versus palbociclib alternating with ICI182,780 treatment in breast cancer cells at 10 weeks.

Project description:We examined differential gene expression profiles between MCF7 human breast cancer cells treated with vehicle alone (control), palbociclib monotherapy, palbociclib alternating with ICI182,780 treatment, and palbociclib resistant cells. For this, we used gene microarray expression profiling to identify significantly changed genes under different treatment conditions.

2023-04-10 | GSE229002 | GEO

Human Breast Cancer cells: Control vs Treated with Palbociclib

Project description:Analysis miRNA profiling of breast cancer cells treated without or with palbociclib.Results provide insight into the molecular mechanisms involved in resistance to pabbociclib.

2020-04-01 | GSE136671 | GEO

Ethanol treated vs paired control

Project description:Ethanol treated vs paired control

| PRJNA92253 | ENA

Arabidopsis: 3OC8-HSL-treated vs Control

Project description:Arabidopsis: 3OC8-HSL-treated vs Control

| PRJNA810497 | ENA

RAW macrophages: Control vs. LPS treated or Immunobiotic treated

Project description:RAW macrophages: Control vs. LPS treated or Immunobiotic treated

| PRJNA880829 | ENA

RNA-seq of human breast cancer cell lines MCF7 and T74D naive and resistant to palbociclib treated with capivasertib, fulvestrant and combination

Project description:T47D and MCF7 cell lines were treated with long-term (continuous) palbociclib to induce 4 resistant cell-lines (T47D RB-, T47D CDK6H, MCF7 RB- and MCF7 PacqR). Each cell line (both parental and resistant) were then treated with DMSO (control), capivasertib monotherapy, fulvestrant monotherapy and capivasertib/fulvestrant combination. RNA data is available after each treatment and resistant cell lines additionally have RNA data available after continuous palbociclib treatment.

2023-08-14 | E-MTAB-13262 | biostudies-arrayexpress

Phospho-proteomic profile of control and Palbociclib-treated HeLa cells

Project description:Liquid Chromatography with tandem mass spectrometry (LC-MS/MS) identification of phosphorylation of control and Palbociclib-treated HeLa cells. For identification and quantification of protein, the single-shot subject samples (DIA MS data) were used to generate a direct-DIA library and computationally merged into a hybrid library in the Spectronaut software (Biognosys). For subsequent data analysis, Gene Ontology (GO) and InterPro (IPR) analysis were conducted using the InterProScan-5 program against the non-redundant protein database, and the databases COG (Clusters of Orthologous Groups) and KEGG (Kyoto Encyclopedia of Genes and Genomes) were used to analyze the protein family and pathway.

2025-12-04 | PXD071048 | Pride

S. coelicolor, control (untreated) vs ciprofloxacin-treated

Project description:S. coelicolor, control (untreated) vs ciprofloxacin-treated

| PRJNA475952 | ENA

Murine testis: control vs. prenatally testosterone treated

Project description:Murine testis: control vs. prenatally testosterone treated

| PRJNA980151 | ENA

Proteomics analysis of Control and Palbociclib-treated HeLa cells

Project description:Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was employed to profile the proteomes of Control and Palbociclib-treated HeLa cells. For protein identification and quantification, mass spectrometry data from fractionated samples (data-dependent acquisition, DDA; 6 fractions) and single-shot samples (data-independent acquisition, DIA) were utilized to construct a DDA library and a direct-DIA library, respectively. These libraries were computationally merged into a hybrid spectral library using Spectronaut software (Biognosys). Subsequent functional annotation was performed through Gene Ontology (GO) and InterPro (IPR) analyses using the InterProScan-5 tool against the non-redundant protein database. Additionally, protein family and pathway analyses were carried out using the Clusters of Orthologous Groups (COG) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) databases.

2025-12-04 | PXD070997 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data